Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexane SCHEMBL3228334 | 0.90 | ALDH1A1 (0.40) | SPHK1LMNATSHR | |
| Hexane SCHEMBL28084958 | 0.85 | TSHR (0.54) | SPHK1LMNATSHRSMN1; SMN2THRB | |
| Dioxane SCHEMBL1463561 | 0.85 | TSHR (0.54) | LMNATSHRSMN1; SMN2POLBHTT | |
| Dioxane SCHEMBL28273076 | 0.82 | SMN1; SMN2 (0.47) | LMNATSHRSMN1; SMN2POLBHTT | |
| Dioxane SCHEMBL28202500 | 0.82 | GPR84 (0.40) | SPHK1LMNAPOLBHTT | |
| Dioxane SCHEMBL29286326 | 0.82 | TSHR (0.57) | LMNATSHRTHRB | |
| Nonane SCHEMBL27725295 | 0.82 | TSHR (0.57) | LMNATSHRTHRB | |
| Heptane SCHEMBL1803195 | 0.82 | TSHR (0.57) | LMNATSHRTHRB | |
| Decane SCHEMBL4618626 | 0.82 | TSHR (0.57) | LMNATSHRTHRB | |
| Tetradecane SCHEMBL28284620 | 0.82 | TSHR (0.57) | LMNATSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180296594-A1 | SOLID ORAL DOSAGE FORM FOR BREAST SYMPTOMS | BioPharmX, Inc. | 2018-10-18 | — | — | US | disclosed |
| US-10034899-B2 | Solid oral dosage form for breast symptoms | BioPharmX, Inc. (US) | 2018-07-31 | — | — | US | disclosed |
| WO-2015080984-A1 | SOLID ORAL DOSAGE FORM FOR BREAST SYMPTOMS | BioPharmX, Inc. (US) | 2015-06-04 | — | — | WO | disclosed |
| US-20150147400-A1 | SOLID ORAL DOSAGE FORM FOR BREAST SYMPTOMS | BioPharmX, Inc (US) | 2015-05-28 | — | — | US | disclosed |